CytoMed Therapeutics Ltd Live Stock Price Today, Share Analysis and Chart

Name: CytoMed Therapeutics Ltd: Is Infosys Ltd. worth buying?
Item: CytoMed Therapeutics Ltd
Rating: 1.26725
Author: Trendlyne DVM scores

about

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of inna...

2.27 0.26 (12.94%)

43.95% Fall from 52W High

64,487

XNAS Volume

High volume+gain today

XNAS 12 Sep, 2025 4:13 PM (EDT)

Not Eligible

Expensive Valuation

5.5 / 100

Technically Neutral

45.2 / 100

1Yr Price target upside is 120%

1 analysts

CytoMed Therapeutics Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..